Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents
- 31 July 2005
- journal article
- research article
- Published by Elsevier BV in Diagnostic Microbiology and Infectious Disease
- Vol. 52 (3), 181-186
- https://doi.org/10.1016/j.diagmicrobio.2005.05.005
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Antimicrobial activity of tigecycline (GAR-936) tested against 3498 recent isolates of Staphylococcusaureus recovered from nosocomial and community-acquired infectionsInternational Journal of Antimicrobial Agents, 2004
- Tigecycline: a first in class glycylcyclineClinical Microbiology Newsletter, 2004
- Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997–2002)Diagnostic Microbiology and Infectious Disease, 2004
- In vitro activity of tigecycline (GAR-936) tested against 11,859 recent clinical isolates associated with community-acquired respiratory tract and gram-positive cutaneous infectionsDiagnostic Microbiology and Infectious Disease, 2004
- Comparison of tetracycline and tigecycline binding to ribosomes mapped by dimethylsulphate and drug-directed Fe2+ cleavage of 16S rRNAJournal of Antimicrobial Chemotherapy, 2004
- In Vitro Activities of Tigecycline (GAR-936) against Multidrug-Resistant Staphylococcus aureus and Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 2004
- In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum β-lactamasesDiagnostic Microbiology and Infectious Disease, 2001
- The Influence of Inadequate Antimicrobial Treatment of Bloodstream Infections on Patient Outcomes in the ICU SettingSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2000
- Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolatesDiagnostic Microbiology and Infectious Disease, 2000
- Disk diffusion susceptibility test development for the new glycylcycline, GAR-936Diagnostic Microbiology and Infectious Disease, 1999